Pacira BioSciences, Inc. (PCRX)

NASDAQ

$36.28

$+11.09

(+44.01%)

Regular Market

Pacira BioSciences, Inc. (PCRX) Live Price Chart

Last updated: ⁦2026-10-08 15:47:20⁩. Prices reflect the latest regular market data. Stock price data is sourced from Massive.

Summary

Pacira BioSciences, Inc. (PCRX) operates in the PHARMACEUTICAL PREPARATIONS sector and is listed on NASDAQ. The stock is currently priced at $36.29, with a market capitalization of $986.98M and a P/E ratio of 68.62. Over the past 52 weeks, its price has ranged from $18.80 to $36.39. This page covers its latest market performance, valuation, price trends and company information.

Key Market Data

Market Cap	$986.98M
Open	$36.33
Day's High	$121.95
Day's Low	$6.16
Previous Close	$25.20
Volume	18.87M
Average Volume	588.29K
P/E Ratio	68.62
52-Week High	$36.39
52-Week Low	$18.80
Dividend Yield	--
Earnings Date	--

Pacira BioSciences, Inc. (PCRX) Stock Price Today

Pacira BioSciences, Inc. (PCRX) is currently trading at $36.29 as of 2026-10-08 15:45:00, up 43.99% ($11.08) from the previous close of $25.20

During today's regular trading session, PCRX has traded between $6.16 and $121.95, with a trading volume of 18.87M shares. The current price is near the lower end of today's range.

Pacira BioSciences, Inc. (PCRX) 7-Day Stock Price Change

Over the past seven days, Pacira BioSciences, Inc. (PCRX) moved from $25.65 to $36.29, representing a gain of 41.46% ($10.63).

The stock traded between $24.56 and $36.39 during the period. The latest price is near the upper end of the 7-day range, indicating strong upward.

The average daily volume was 586.94 thousand shares, up versus the previous seven-day period, indicating higher trading activity.

PCRX 52-Week Price Position

Position in Range: 99.4%

52W Low$18.80

52W High$36.39

PCRX is currently trading at $36.29, placing it 99.4% of the way from its 52-week low of $18.80 to its 52-week high of $36.39. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.

What is Pacira BioSciences, Inc. (PCRX)?

Pacira BioSciences Inc is a provider of non-opioid pain management and regenerative health solutions dedicated to advancing and improving outcomes for healthcare practitioners and their patients. The company's commercialized non-opioid treatments: EXPAREL a long-acting, local analgesic currently approved for postsurgical pain management; ZILRETTA, an extended-release, intra-articular, corticosteroid injection indicated for the management of osteoarthritis; and iovera, a novel, handheld device for delivering immediate, long-acting, drug-free pain control using precise, controlled doses of cold temperature to a targeted nerve. In addition, it is developing PCRX-201 (enekinragene inzadenovec), a novel gene therapy vector platform for the treatment of osteoarthritis of the knee.

Pacira BioSciences, Inc. Information

Industry	PHARMACEUTICAL PREPARATIONS
Employees	829
Exchange	NASDAQ
Company Website	https://www.pacira.com

How to Buy Pacira BioSciences, Inc. (PCRX) Stock on MEXC

Eligible investors can buy real shares of Pacira BioSciences, Inc. (PCRX) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.

Step 1: Open and Verify Your RealStocks Account

Log in to the MEXC App, go to Trade → RealStocks, and select Open Account. Complete the required account-opening and identity verification process with MEXC's partner licensed broker.

Step 2: Transfer USDT to Your RealStocks Account

Go to Wallets → RealStocks and transfer USDT from your Spot Account to your RealStocks Account. RealStocks are quoted in USD, while account funding can be completed using USDT.

Step 3: Search for PCRX and Place Your Order

Open the RealStocks trading page and search for PCRX. Select a market or limit order, enter the price and quantity as required, review the order details, and submit your order. Once filled, the corresponding real shares will be held in your RealStocks Account.

Frequently Asked Questions (FAQ)

1.What is Pacira BioSciences, Inc. (PCRX) stock price today?

Pacira BioSciences, Inc. (PCRX) is currently trading at $ 36.29, up 43.99% ($11.08) from the previous close of $ 25.20. Intraday prices update in real time during regular trading hours.

2.Is PCRX stock going up or down today?

As of 2026-10-08 15:45:00, PCRX is trading at $ 36.29, up 43.99% ($11.08) from its previous close of $ 25.20. The stock has traded between $ 6.16 and $ 121.95 during today’s regular session. Past price movements do not guarantee future results.

3.What is PCRX pre-market price?

As of 2026-10-08 15:45:00, PCRX is trading at $ 36.34 in pre-market trading, up 44.19% ($11.14) from the previous close of $ 25.20. Pre-market prices reflect trading activity before the regular session opens and may experience lower liquidity and higher volatility.

4.What is PCRX after-hours price?

As of 2026-10-08 15:45:00, PCRX is trading at $ 25.22 in after-hours trading, up 0.06% ($0.02) from the regular-session close of $ 25.20. After-hours prices may differ from the regular session’s opening price due to lower liquidity and wider bid-ask spreads.

5.Is PCRX stock trading now?

PCRX trades on the NASDAQ exchange during regular hours, Monday through Friday, 9:30 AM to 4:00 PM ET, excluding public holidays. Pre-market and after-hours trading are also available through select brokers outside these hours.

6.Where does PCRX sit relative to its 52-week high and low?

Over the past 52 weeks, PCRX has traded between a low of $ 18.80 and a high of $ 36.39. At $ 36.29, the stock is positioned 99.4% of the way from its 52-week low to its 52-week high, providing context for its current price within the one-year trading range.

7.What sector is Pacira BioSciences, Inc. in?

Pacira BioSciences, Inc. (PCRX) operates in the PHARMACEUTICAL PREPARATIONS sector. Sector classification helps investors compare it with companies exposed to similar market trends and competitive conditions.

8.What is Pacira BioSciences, Inc.'s market capitalization and where is it listed?

Pacira BioSciences, Inc. is listed on the NASDAQ exchange with a market capitalization of $ 986.98M. Market cap reflects the total market value of all outstanding shares and is commonly used to classify stocks by size.

9.How is PCRX valued in terms of P/E ratio and EPS?

PCRX trades at a P/E ratio of 68.62, based on trailing-twelve-month EPS of $ 0.37. P/E ratio compares the stock price to earnings per share and is a common starting point for assessing valuation relative to peers.

10.Does Pacira BioSciences, Inc. pay a dividend?

Pacira BioSciences, Inc. pays an indicated annual cash dividend of $ 0.00 per share, with a current dividend yield of 0.00% based on the latest share price. Dividend policies are subject to change at the board's discretion.